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Essential oils from herbs and roots of Conyza canadensis (horseweed), collected in Hungary, were obtained by hydrodistillation.
The chemical compositions of the oils were analysed by combination of GC and GC/MS. The major constituent of the oil obtained
from the aerial parts of horseweed was limonene (78%), while the main component of root oil was 2Z,8Z-matricaria ester. The
antimicrobial activities of the oils were tested on Gram-positive (Enterococcus faecalis, Staphylococcus aureus, and Streptococcus
pyogenes), Gram-negative (Escherichia coli, Pseudomonas aeruginosa) bacteria, reference fungal strains, and fungal strains isolated
from patients (Candida, Cryptococcus, Trichophyton, Rhodotorula, and Aspergillus) by agar disc diﬀusion and broth dilution
methods. None of the oils showed any activity against the tested bacterial strains, but exhibited moderate-to-strong activity against
all fungi with the only exception of A. fumigatus. The highest zone of inhibition was observed in case of Cryptococcus neoformans
and Trichophyton interdigitalis
1. Introduction
Conyza canadensis (L.) Cronq. (formerly Erigeron canadensis
L.; horseweed or canadian fleabane, Asteraceae) is indige-
nous to North America but is globally distributed today and
widely found in Hungary. The aerial parts and the roots of
this plant have been used all over the world as traditional or
oﬃcial herbal medicines for the treatment of gastrointestinal
symptoms, most commonly diarrhoea and dysentery, and as
diuretic agent [1]. In Chinese folk medicine, horseweed has
also been applied for the treatment of wounds, swellings,
and pain caused by arthritis [2]. Moreover, the volatile oil
of horseweed has been applied against bronchitis and cystitis
[3].
Phytochemical studies of C. canadensis revealed the
presence of C10 acetylenes [4, 5], sesquiterpene hydrocarbons
[6], flavonoids [7], sterols, triterpenes, and sphingolipids [8–
10]. The essential oil of juvenile and mature herbs collected
in Washington State (USA) was previously analyzed by
Hrutfiord et al.; twenty-five constituents, includingmonoter-
penes, sesquiterpenes, and acetylenes were identified, and the
predominance of limonene (67.25%) was confirmed [11]. In
a sample of aerial parts collected in France, 18 compounds
were detected with limonene as themain constituent (76.0%)
[12]. The analysis of the essential oil of aerial part of
horseweed growing in Japan led to the detection of 47 volatile
components of which 91.0% were terpenoid. The main
constituent was limonene (31.2%). Some nonterpenoid
acetylenic compounds were also detected [13].
In the present study the composition of essential oils
obtained from roots and herbs of Hungarian population of
C. canadensis was analyzed, and the antimicrobial activities
of the oils against human pathogenic bacteria and fungi were
evaluated for the first time.
2. Material andMethods
2.1. Plant Material. Roots (roots 1) and flowering shoots
of Conyza canadensis were collected in Szeged (Hungary)
in July 2009. Further sample from horseweed roots (roots
2) was gathered in Jakabsza´lla´s (Hungary) in September
2009. The comminuted plant materials were dried at room
temperature. 85.5 g of the shoots, 94.9 g of the roots 1, and
50.45 g of the roots 2 were used for the hydrodistillation.


































Figure 1: Total ion chromatogram of the essential oil of Conyza canadensis (a) oil distilled from the herbs, (b) oil distilled from the roots I.
Voucher specimens (No. 804 and 805) have been deposited
at the Department of Pharmacognosy, University of Szeged.
2.2. Isolation of the Essential Oil. The dried flowering shoots
and roots were cut oﬀ and were subjected to hydrodistillation
for 2 hours, according to the method of Ph. Eur 6.0 [14]. The
obtained essential oils were dried over anhydrous sodium
sulphate, filtered, and stored at −18◦C. The yields were
calculated on the basis of the dry weight of the plant
materials. The compositions of the oils were studied by GC
and GC-MS techniques.
2.3. Gas Chromatography. The GC analysis was carried out
with an HP 5890 Series II gas chromatograph (FID), using a
30m×0.35mm×0.25μmHP-5 fused silica capillary column.
The temperature program was from 60◦C to 210◦C at 3◦C
min−1 and from 210◦C to 250◦C (2min hold) at 5◦C min−1.
The detector and injector temperature was 250◦C, and the
carrier gas was N2, with split sample introduction.
2.4. Gas Chromatography-Mass Spectrometry. GC-MS analy-
sis was performed with a FINNIGAN GCQ ion trap bench-
top mass spectrometer. All conditions were as above except
that the carrier gas was He at a linear velocity of 31.9 cmsec−1
and the capillary column was DB-5MS (30m × 0.25mm ×
0.25μm). Positive ion electron ionization mode was used,
with a mass range of 40–400 amu. The constituents were
identified by comparing their Rts and Kovats indices with
published MS data [15] and from computer library searches.
The identification was further confirmed with the aid of
authentic samples (Extrasynthese, Genay, France). Kovats
indices were calculated mainly from the GC-MS analysis
results [16].
2.5. Bacteriostatic and Fungistatic Activities. Bacterial strains:
Enterococcus faecalis (ATCC29212), Staphylococcus aureus
(ATCC25923), Streptococcus pyogenes (HNCMB80002)
Gram-positive bacteria; Escherichia coli (ATCC25922),
Pseudomonas aeruginosa (ATCC27853) Gram-negative bac-
teria. Fungal strains: Candida albicans (UK-NEQUAS4661),
Candida glabrata (ATCC90030), Candida parapsilosis
(ATCC22019), Candida tropicalis (UK-NEQUAS4893),
Cryptococcus neoformans (INF5855) reference fungal strains,
and Candida kefyr, Rhodotorula glutinis, Trichophyton
interdigitalis, Aspergillus fumigatus fungal strains isolated
from patients.
The bacteriostatic and fungistatic activities were deter-
mined by agar-diﬀusion method. Diﬀerent nutrient agars
were used: Mueller-Hinton agar (MHA) for the bacteria
strains (except S. pyogenes), Blood agar (BA) for the S.
pyogenes strain, and Mueller-Hinton modified agar (MH-
GMB) for C. neoformans and Sabouraud dextrose agar
(SDA) for the fungal/yeast strains. Agars were distributed
to sterilized Petri dishes with a diameter of 9 cm (15mL).
The filter paper discs (6mm in diameter) were placed onto
the agar plates which had previously been inoculated with
the tested microorganisms, and then the filter paper discs
were individually impregnated with 8 μg of the essential oil.
The Petri dishes were kept at 4◦C for 30min and then at
room temperature for 30min. The plates were inoculated
with bacteria, incubated at 37◦C for 24 h, and for 48 h for
the yeasts and fungal strains. The diameters of the inhibition
zones were measured in millimetres. Piperacillin/tazobactam
(100/10 μg), fluconazole (25 μg), and voriconazole (1 μg)
served as positive controls.
The MIC (minimal inhibitory concentration) values
were determined with the broth dilution assay. MIC values
were measured in sterile 96-well microtiter plates. 100 μL
aliquots of blank solvent, positive control, and oil solution
(dissolved in DMSO at 20 v/v%) were pipetted into the
wells in the 1–3 column of the plate, 50 μL of phosphate-
buﬀered saline (PBS) solution into the wells in columns
4–12. The samples of the oils in the third column were
diluted with an 8-channel pipette with 50 μL from the 3rd
column to the 12th. The 24 h cultured yeast strains were
diluted 100-fold in SDA for the Candida strains and 10-fold
for the C. neoformans and R. glutinis strains. From these
suspensions, 50 μL was added to each well. The samples were
then incubated for 48 hours at room temperature in case of
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2E-hexanal 0.1 873 c
α-pinene 0.3 936 c, d
Sabinene tr 978 c, d
β-pinene 2.8 1.3 985 c, d
Myrcene 1.5 992 c
p-cymene tr 1020 c, d
limonene 79.2 1.0 1038 c, d
trans-ocimene 0.9 1050 c
2,5-dimethyl styrene 0.1 1101 c
E,E-cosmene 0.4 1132 c
cis-verbenol 0.5 1142 c
trans-sabinol 0.4 1147 c
2-allyl-phenol 0.2 1199 c
Myrtenol 0.3 1208 c
cis-p-mentha-1(7),8-dien-2-ol 0.8 1232 c
trans-chrysanthenyl acetate 0.3 1245 c
Modheph-2-ene 0.1 1389 c
β-caryophyllene 0.2 1427 c, d




11-αH-himachala-1,4-diene 0.2 1495 c
4E,8Z-matricaria lactone 0.7 1490 c, d
δ-cadinene 0.2 1526
8Z-2,3-dihydromatricaria ester 1.0 3.3 2.6 1537 c
2E,8Z-matricaria ester 0.3 1.9 0.9 1540 c
2Z,8Z-matricaria ester 2.1 88.2 93.9 1551 c
4Z,8Z-matricaria lactone tr 2.3 2.5 1560 c
Germacrene B 0.2 1567 c
2E,8E-matricaria ester — 0.7 1597 c
Spathulenol 0.3 1581
ar-turmerone 0.1 1590 c
β-copaen-4-α-ol 0.4 1595 c
Salvia-4(14)-en-1-one 0.2 1610 c
Total 98.0 98.6 99.9
a
Compounds listed in sequence of elution from a CB-5 MS column.
bKovats retention indices calculated against C9 to C24 n-alkanes on a CB-5 MS column.
cComparison of mass spectra with MS libraries and retention indices.
dComparison with authentic compound.
the yeasts. The MIC was defined as the lowest concentration
of the test sample that resulted in a complete inhibition of
visible growth in the broth. DMSO was used as a negative
control, while fluconazole was applied as a positive control.
3. Results and Discussion
Essential oils from herbs and two samples of roots of C.
canadensis were prepared by hydrodistillation. The essential
oil content of the roots was much lower (0.20%) than that
of the herbs (0.72%). Chemical composition of the oils
was analysed by combination of GC and GC/MS (Figure 1)
and substantial diﬀerences were found between the two
investigated plant parts. Table 1 presents the results of the
qualitative and quantitative analyses. The essential oil of the
herbs was found to bemore complex than the oil of the roots.
In the essential oil of the herbs 34 components were detected
while in the essential oil of the roots only 9 components could
be observed. The identified constituents represented 98.0–
99.9% of the oils. The major constituent of the oil of the
aerial parts was limonene (79.2%). Further compounds were
mono- and sesquiterpenes in 8.6% and 6.6%, and acetylenes
in 3.4%. The main component of the oil obtained from
the roots was the acetylene compound, 2Z,8Z-matricaria
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Enterococcus faecalis NA NA 25 NT ND
Staphylococcus aureus NA NA 30 NT ND
Streptococcus pyogenes NA NA 35 NT ND
Escherichia coli NA NA 25 NT ND
Pseudomonas aeruginosa NA NA 30 NT ND
Candida albicans 15 20 NT 30 40
Candida glabrata 25 25 NT NA NA
Candida kefyr 7 9 NT 50 50
Candida parapsilosis 13 18 NT 28 30
Candida tropicalis 15 18 NT 18 12
Cryptococcus neoformans 40 32 NT 25 35
Rhodotorula glutinis 13 18 NT 30 30
Trichophyton interdigitalis 40 40 NT NA > 40
Aspergillus fumigatus NA NA NT NA 18
a
Diameter of inhibition zone (mm) including diameter of the paper disc (6mm).
NA: not active.
NT: not tested.









Candida albicans 5.00 10.00 0.195 >20
Candida glabrata 2.50 2.50 NA >20
Candida kefyr 10.00 20.00 0.195 >20
Candida parapsilosis 10.00 10.00 0.39 >20
Candida tropicalis 2.50 2.50 50.00 >20
Cryptococcus neoformans 1.25 1.25 25.00 >20
Rhodotorula glutinis 2.50 2.50 25.00 >20
NA: not active.
ester (88.2%; 93.9%), and three other acetylenes (8Z-
2,3-dihydromatricaria ester, 2E,8Z-matricaria ester, 4Z,8Z-
matricaria lactone) were present in smaller amounts. Addi-
tional diﬀerences were observed in the minor components of
the two diﬀerent root samples; β-pinene, limonene, 4E,8Z-
matricaria lactone, and 4Z,8Z-matricaria lactone were found
only in roots 1. Interestingly the main compound of the root
2Z,8Z-matricaria ester can be detected in herb only in small
quantity, and, reversed, the main component of the herb
limonene is present in the root oil only in 1%.
The antimicrobial activities of oils of the herbs and roots
1 were tested on Gram-positive and Gram-negative bacteria,
reference fungal strains, and fungal strains isolated from
patients. The agar diﬀusion method furnished semiquanti-
tative data on the bacteriostatic and fungistatic eﬀects of the
oils (Table 2). No substantial diﬀerences were found between
the activities of the studied essential oils; none of them
showed any activity against the tested bacterial strains, but
exhibited moderate-to-strong activity against all fungi with
the only exception of Aspergillus fumigatus. The highest zone
of inhibition was observed against Cryptococcus neoformans
and Trichophyton interdigitalis.
In order to quantitate the antimicrobial activity of the
essential oils, the minimal inhibitory concentrations (MIC)
were determined in case of selected fungal strains. The MIC
values varied from 1.25 μg/mL to 20.00 μg/mL for the tested
fungal strains (Table 3). The highest antifungal potency was
exhibited by herb and root oils against Cryptococcus neofor-
mans with 1.25 μg/mL MIC values. In addition, substantial
eﬃcacy (MIC = 2.50 μg/mL) was detected against other
Candida strains (C. glabrata, C. tropicalis) and Rhodotorula
glutinis.
In summary, the composition of the essential oil of the
roots of C. Canadensis is described for the first time, with
the C10 acetylene-type compound 2Z,8Z-matricaria ester
as the main component, similarly to the closely related
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species E. acris and E. annuus [17]. In accordance with
previous analyses [11–13], limonene was detected as the
predominant component of the essential oil of aerial parts of
horseweed. The antifungal activity of the essential oil of aerial
parts has been investigated previously against various phy-
topathogenic fungi [12]; however our experiments provide
the first information about the marked antifungal activity
against human pathogenic strains in vitro. Further studies
are needed to evaluate the in vivo potential of these oils in
animal models.
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